Amazon's $3 trillion valuation, achieved this week, is being treated as an artificial intelligence and cloud computing milestone. For retail leaders, it should be read as a broader signal that investors value the infrastructure surrounding commerce as much as the sale itself.
The tech stocks landscape is a complicated one right now. Investors have so many options, with technology equities delivering for portfolios year in and year out.
Amazon surpassed a $3 trillion market cap, driven by record Q2 2026 results and robust fundamentals, not just multiple expansion. Q2 revenue reached $200.61 billion (+20% YoY), AWS grew 36.7% YoY, and operating income soared 43% YoY to $27.5 billion with a 13.7% margin. CapEx guidance increased to $220 billion for 2026, but management emphasized demand is locked in, with a $496 billion AWS backlog growing triple digits YoY.
Its performance may be volatile, but it's certainly working well enough right now.
Bezos' planned $4B AMZN share sale sparks a pullback, but strong AWS, AI and retail momentum suggest the move doesn't alter the company's growth story.
Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its healthcare business by offering popular weight-loss medications
Amazon owns more than a fifth of Anthropic. Anthropic's upcoming IPO could be a major catalyst for Amazon's stock.
Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo will be available at a cost of $50 a month.
Amazon (NASDAQ:AMZN | AMZN Price Prediction) is spending a fortune on the AI effort.
More than 66 million. That's how many people in the U.S. get their health coverage from Medicare, according to the insurance program.